ERS International Congress 2023: highlights from the Respiratory Clinical Care and Physiology Assembly.

It is a challenge to keep abreast of all the clinical and scientific advances in the field of respiratory medicine. This article contains an overview of laboratory-based science, clinical trials and qualitative research that were presented during the 2023 European Respiratory Society International Congress within the sessions from the five groups of Assembly 1 (Respiratory Clinical Care and Physiology). Selected presentations are summarised from a wide range of topics: clinical problems, rehabilitation and chronic care, general practice and primary care, electronic/mobile health (e-health/m-health), clinical respiratory physiology, exercise and functional imaging.
Competing Interests: Conflict of interest: C-Y. Hui is a visitor at the University of Edinburgh and is a senior consultant in healthcare sustainability at Turner and Townsend. Her research with the University of Edinburgh is independent from, and not financially supported by, Turner and Townsend. Her views in this publication and the ERS Congress are her own, and not those of Turner and Townsend. Neither she, nor Turner and Townsend, stand to gain financially from work reported in this publication. Conflict of interest: C. Vicente reports personal fees from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline and Mylan, outside the submitted work. Conflict of interest: V. Poberezhets reports personal fees from AstraZeneca outside the submitted work. Conflict of interest: F.M.E. Franssen reports grants and personal fees from AstraZeneca, Chiesi, GlaxoSmithKline and Sanofi, and personal fees from Pieris, outside the submitted work. Conflict of interest: I. Vogiatzis is an associate editor of this journal. Conflict of interest: T. Gille reports personal fees from Roche SAS, outside the submitted work. Conflict of interest: The other authors have nothing to disclose.
(Copyright ©The authors 2024.)